➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
McKinsey
Mallinckrodt
Medtronic

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 7,813,418

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,813,418
Title:Method and a multi-carrier transceiver supporting dynamic switching between active application sets
Abstract: A transceiver and method for communicating over a communications channel having a plurality of subchannels are described. In particular, the transceiver is capable of dynamically switching between communicating data for a first active application set and communicating data for a second different active application set. An active application set is defined as the set of one or more active applications for which the transceiver is currently communicating data. As part of communicating data for the first active application set, the transceiver allocates the subchannels to the one or more applications in the first application set. The transmission requirements of the first active application set defines a first communication state of the transceiver. When the transceiver dynamically transitions to communicating data for the second different application set, the transceiver reallocates the subchannels to the one or more applications in the second different application set. The transmission requirements of the second different active application set defines a second communication state of the transceiver. In one embodiment the transceiver modifies the data rates of subchannels in the Bit Allocation Table according to the transmission requirements of the application whose data is being transmitted on the particular subchannel. In another embodiment, the transceiver is capable of dynamically switching from transmitting data for an Internet access application to transmitting data for a voice telephony application in addition to the Internet access application. In a further embodiment, the ABCD voice telephony signaling bits can be transmitted with either the data from the Internet access application or the data from the voice telephony application.
Inventor(s): Tzannes; Marcos C. (Orinda, CA), Tzannes; Michael A. (Lexington, MA), Hunter; David C. (Winchester, MA), Gross; Richard W. (Acton, MA), Padir; Halil (North Andover, MA)
Assignee:
Application Number:12/013,043
Patent Claims:see list of patent claims

Details for Patent 7,813,418

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2019-03-12 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Merck
Dow
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.